Picture [iito] No Tracking 650x80px
Document › Details

Novacyt S.A.. (9/26/18). "Press Release: Novacyt Half Year 2018 Results. Molecular Product Revenues up 18% to €3m – Gross Margin Increases to 64%". Paris & Camberley.

Organisations Organisation Novacyt S.A. (Alternext: ALNOV)
  Group Novacyt (Group)
  Organisation 2 Lab21 Ltd.
  Group Novacyt (Group)
Products Product clinical diagnostics
  Product 2 NovaPrep®
Person Person Mullis, Graham (Novacyt 201409 CEO before Lab21 CEO)

Record changed: 2018-09-28


Picture ConsulTech GmbH RnD Credit Germany 650x80px

More documents for Novacyt (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80

» top